Oncothermia as Personalized Treatment Option

Table 1

List of oncothermia studies. Some references of various localizations: bone (metastatic) [16, 17]; breast [18]; colorectal [19–23]; gliomas [24–33]; esophagus [34]; brain (metastatic) [21]; kidney [35]; liver (primary) [36], liver (metastatic) [37, 38]; lung (NSCLC) [39, 40]; lung (SCLC), [38, 41]; and pancreas [42–45].

Study	Number of studies	Number of patients (𝑛)	1st year survival (%)	Median overall survival (m)
Brain studies	10	521	73.99	22.19
Pancreas studies	6	184	47.04	11.02
Lung studies	5	636	64.76	15.79
Bone	3	79		40.10
Liver metastasis	7	267	86.00	18.06
Colorectal	7	447
Gynecology (pelvic)	5	100	93.22	33.25
Breast	1	103	97.10	52.10
Esophagus	2	19	41.70	55.64
Stomach study	1	68	58.90	14.40
Kidney cancer	1	39	84.60	35.90
Urinary bladder cancer	1	18	85.00	36.50
Head and neck	1	64	92.20	26.10
Soft tissue sarcoma	1	16	100.00	35.90
Prostate	3	135	88.90	38.80
Sum	54	2796